Literature DB >> 18274074

Scattered neutron dose equivalent from an active scanning proton beam delivery system.

Draik Hecksel1, George A Sandison, Jonathan B Farr, Andrew C Edwards.   

Abstract

A study of neutron production from a novel active scanning proton beam delivery system at the Midwest Proton Radiotherapy Institute (MPRI) has been performed. The neutron dose equivalent was determined using a neutron rem (roentgen equivalent in man) detector which has an upper energy limit of 10 MeV. Measurement were taken at 0, 45, and 90 degrees from the proton beam central axis and for various proton beam energies (127-208 MeV) and scanned field sizes (25-144 cm2). The maximum neutron dose observed was 0.43 mSv / (proton treatment Gy) at 90 degrees from the beam axis for a beam energy of 208.4 MeV and a scanned field size of 144 cm2. It is still possible to further mitigate this secondary neutron dose during treatment by optimizing parameters within the treatment nozzle and using shielding.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18274074

Source DB:  PubMed          Journal:  Australas Phys Eng Sci Med        ISSN: 0158-9938            Impact factor:   1.430


  3 in total

1.  Monte Carlo and analytical model predictions of leakage neutron exposures from passively scattered proton therapy.

Authors:  Angélica Pérez-Andújar; Rui Zhang; Wayne Newhauser
Journal:  Med Phys       Date:  2013-12       Impact factor: 4.071

2.  Microdosimetric measurements for neutron-absorbed dose determination during proton therapy.

Authors:  Angélica Pérez-Andújar; Paul M Deluca; Allan F Thornton; Markus Fitzek; Draik Hecksel; Jonathan Farr
Journal:  Radiat Prot Dosimetry       Date:  2012-02-14       Impact factor: 0.972

3.  Reduction of the secondary neutron dose in passively scattered proton radiotherapy, using an optimized pre-collimator/collimator.

Authors:  David J Brenner; Carl D Elliston; Eric J Hall; Harald Paganetti
Journal:  Phys Med Biol       Date:  2009-09-24       Impact factor: 3.609

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.